Hmm. I think we can be confident that with growth 'always increasing', executive remuneration in this company will also keep increasing. As for net profit ... well, time will tell.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025